Neuberg Launches Personalized Genomics Platform ‘Geniee’

Neuberg’s Geniee allows users to access detailed information about their genetic makeup and provides insights into their dietary needs, and nutrient intake. 

Neuberg Diagnostics has launched a new personalized genomics platform, ‘Geniee – Decode Your DNA,’ to improve healthcare through insights based on individual genetic makeup.

The platform marks Neuberg Diagnostics’ entry into the field of genetic testing, allowing users to understand better how their genes influence health, wellness, and medical treatment.

Dr GSK Velu, chairman and MD of Neuberg Diagnostics, said, “At Neuberg, we believe that personalized medicine is the future of healthcare. The launch of Geniee is a testament to our commitment to driving this future forward. Geniee is not just about testing—it’s about giving individuals the power to take control of their health by offering them invaluable insights.”

Genomics Platform Geniee’s Offerings

The Geniee platform allows users to access detailed information about their genetic makeup, providing insights into how their bodies respond to medications, dietary needs, exercise routines, and nutrient intake. 

This information allows individuals to make informed decisions to optimise their diets, address nutrient deficiencies, and enhance fitness plans, helping to prevent potential health issues before they arise.

The heart of this initiative is the Complete Wellness Genetics Test, which offers a comprehensive genetic analysis. This test helps identify whether an individual is predisposed to obesity or has nutritional deficiencies. 

Additionally, it provides tailored recommendations for food and lifestyle changes to improve overall health outcomes. The platform will also keep users updated with new genomic research as it becomes available, ensuring they have access to the latest insights.

Neuberg’s Tailored Treatments

The Geniee platform is built on the principles of pharmacogenomics, which studies how an individual’s genetic makeup impacts their medication response. 

This personalized approach is intended to move away from the traditional one-size-fits-all model of prescribing medications and focus instead on tailoring treatments to the patient’s genetic profile. 

Furthermore, by understanding how genetic factors affect drug metabolism and response, healthcare professionals can make better decisions on medication types and dosages, potentially reducing adverse drug reactions and improving treatment outcomes.

Dr Sandip Shah, Joint MD of Neuberg Diagnostics, highlighted the significance of this approach, stating, “Pharmacogenomics is at the heart of Geniee, and it is changing the landscape of medicine. It represents a paradigm shift in healthcare, where the one-size-fits-all approach is replaced with tailored treatments based on a person’s genetic makeup.”

Dr Shah added that recent studies have shown that individuals in India carry an average of eight genetic variants that directly influence their medication response. 

These findings underline the importance of adopting personalized medicine, particularly in reducing the risk of adverse drug reactions and improving the efficacy of treatments.

The Geniee platform also focuses on proactive healthcare by promoting the early detection of health risks and offering personalized health plans. The aim is to make healthcare more accessible, helping individuals take preventive steps based on their genetic profiles. 

By identifying risks early and providing tailored recommendations, the platform hopes to empower individuals to take charge of their health more effectively.

Stay tuned for more such updates on Digital Health News.